Mereo BioPharma Stock Forward View - Accumulation Distribution

MREO Stock  USD 0.40  0.01  2.44%   
Mereo Stock outlook is based on your current time horizon.
As of today the rsi of Mereo BioPharma's share price is below 20 . This indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of Mereo BioPharma's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Mereo BioPharma Group, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Mereo BioPharma's stock price prediction:
EPS Estimate Next Quarter
(0)
EPS Estimate Current Year
(0.04)
EPS Estimate Next Year
(0.02)
Wall Street Target Price
2.6763
EPS Estimate Current Quarter
(0)
Using Mereo BioPharma hype-based prediction, you can estimate the value of Mereo BioPharma Group from the perspective of Mereo BioPharma response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Mereo BioPharma using Mereo BioPharma's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Mereo using crowd psychology based on the activity and movement of Mereo BioPharma's stock price.

Mereo BioPharma Short Interest

An investor who is long Mereo BioPharma may also wish to track short interest. As short interest increases, investors should be becoming more worried about Mereo BioPharma and may potentially protect profits, hedge Mereo BioPharma with its derivative instruments, or be ready for some potential downside.
200 Day MA
1.8427
Short Percent
0.0867
Short Ratio
0.29
Shares Short Prior Month
9.8 M
50 Day MA
1.1524

Mereo Relative Strength Index

Mereo BioPharma Group Hype to Price Pattern

Investor biases related to Mereo BioPharma's public news can be used to forecast risks associated with an investment in Mereo. The trend in average sentiment can be used to explain how an investor holding Mereo can time the market purely based on public headlines and social activities around Mereo BioPharma Group. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Mereo BioPharma's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Mereo BioPharma.

Mereo BioPharma Implied Volatility

    
  1.17  
Mereo BioPharma's implied volatility exposes the market's sentiment of Mereo BioPharma Group stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Mereo BioPharma's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Mereo BioPharma stock will not fluctuate a lot when Mereo BioPharma's options are near their expiration.

Mereo BioPharma after-hype prediction price

    
  USD 0.38  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Mereo BioPharma to cross-verify your projections.

Prediction based on Rule 16 of the current Mereo contract

Based on the Rule 16, the options market is currently suggesting that Mereo BioPharma Group will have an average daily up or down price movement of about 0.0731% per day over the life of the 2026-05-15 option contract. With Mereo BioPharma trading at USD 0.4, that is roughly USD 2.93E-4 . If you think that the market is fully incorporating Mereo BioPharma's daily price movement you should consider acquiring Mereo BioPharma Group options at the current volatility level of 1.17%. But if you have an opposite viewpoint you should avoid it and even consider selling them.

Open Interest Against 2026-05-15 Mereo Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Mereo BioPharma's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Mereo BioPharma's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Mereo BioPharma stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Mereo BioPharma's open interest, investors have to compare it to Mereo BioPharma's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Mereo BioPharma is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Mereo. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.

Mereo BioPharma Additional Predictive Modules

Most predictive techniques to examine Mereo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Mereo using various technical indicators. When you analyze Mereo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Mereo BioPharma Group has current Accumulation Distribution of 158827.0. The accumulation distribution (A/D) indicator shows the degree to which Mereo BioPharma is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Mereo BioPharma Group to determine if accumulation or reduction is taking place in the market. This value is adjusted by Mereo BioPharma trading volume to give more weight to distributions with higher volume over lower volume.
Check Mereo BioPharma VolatilityBacktest Mereo BioPharmaInformation Ratio  

Mereo BioPharma Trading Date Momentum

On February 11 2026 Mereo BioPharma Group was traded for  0.40  at the closing time. The top price for the day was 0.42  and the lowest listed price was  0.38 . The trading volume for the day was 1.7 M. The trading history from February 11, 2026 did not cause price change. The trading delta at closing time against the current closing price is 2.50% .
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare Mereo BioPharma to competition

Other Forecasting Options for Mereo BioPharma

For every potential investor in Mereo, whether a beginner or expert, Mereo BioPharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Mereo Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Mereo. Basic forecasting techniques help filter out the noise by identifying Mereo BioPharma's price trends.

Mereo BioPharma Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Mereo BioPharma stock to make a market-neutral strategy. Peer analysis of Mereo BioPharma could also be used in its relative valuation, which is a method of valuing Mereo BioPharma by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Mereo BioPharma Market Strength Events

Market strength indicators help investors to evaluate how Mereo BioPharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Mereo BioPharma shares will generate the highest return on investment. By undertsting and applying Mereo BioPharma stock market strength indicators, traders can identify Mereo BioPharma Group entry and exit signals to maximize returns.

Mereo BioPharma Risk Indicators

The analysis of Mereo BioPharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Mereo BioPharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting mereo stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Story Coverage note for Mereo BioPharma

The number of cover stories for Mereo BioPharma depends on current market conditions and Mereo BioPharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Mereo BioPharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Mereo BioPharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Mereo BioPharma Short Properties

Mereo BioPharma's future price predictability will typically decrease when Mereo BioPharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Mereo BioPharma Group often depends not only on the future outlook of the potential Mereo BioPharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Mereo BioPharma's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding147.9 M
Cash And Short Term Investments69.8 M
When determining whether Mereo BioPharma Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mereo BioPharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mereo Biopharma Group Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mereo Biopharma Group Stock:
Check out Historical Fundamental Analysis of Mereo BioPharma to cross-verify your projections.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Will Biotechnology sector continue expanding? Could Mereo diversify its offerings? Factors like these will boost the valuation of Mereo BioPharma. Expected growth trajectory for Mereo significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Mereo BioPharma data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(0.27)
Revenue Per Share
0.003
Return On Assets
(0.40)
Return On Equity
(0.70)
Investors evaluate Mereo BioPharma Group using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Mereo BioPharma's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Mereo BioPharma's market price to deviate significantly from intrinsic value.
Understanding that Mereo BioPharma's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Mereo BioPharma represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Mereo BioPharma's market price signifies the transaction level at which participants voluntarily complete trades.